Research

Devi G. The Certain Uncertainty of an Alzheimer's Disease Diagnosis. Ann Intern Med. Jan 2026.

Mervosh N, Bilici N, Wisniewski T, Devi G. Reducing ARIA risk in Alzheimer's disease: Real-world impact of APOE genotype-guided slow titration with aducanumab and lecanemab. J Alzheimers Dis. 2025 Oct;107(4):1400-1403.

Mervosh N, Devi G. Estrogen, menopause, and Alzheimer's disease: understanding the link to cognitive decline in menopause. Front Mol Biosci. 2025;12.

Devi G. Minimizing risk of amyloid-related imaging abnormalities in Alzheimer's patients on anti-amyloid monoclonal antibody therapy through lower dose titration. Intl Conf Alzheimer's & Parkinson's Disease, AD/PD 2025, Austria.

Hagerman TK, Suh M, Devi G, et al. Emergency care for patients on amyloid-targeting therapies in Alzheimer's disease. J Geriatr Emer Med. 2024. doi:10.17294/2694-4715.1085.

Devi G. A how-to guide for a precision medicine approach to the diagnosis and treatment of Alzheimer's disease. Front Aging Neurosci. 2023;15.

Devi G. Tauopathies. Chapter in Handbook of Clinical Neurology. Younger DS, Boller F, Eds. Elsevier, 2023.

Devi G. Tolerability and safety of aducanumab in a community setting. J Am Geriatr Soc. 2022.

Devi G. Menopause related cognitive impairment. Annual Meeting, International Menopause Society, 2013, London.

Tumasian R, Devi G. Off-label transcranial magnetic stimulation in amnestic mild cognitive impairment and Alzheimer's disease: A twelve-year case series in a single clinic. Brain Stimulation. 2021;14:751-753.

Devi G. Tolerability and safety of aducanumab in a community setting. J Am Geriatr Soc. 2022. doi:10.1111/jgs.18059.

Devi G, Gitelman D, Press D, Daffner K. Cognitive impairment in aging physicians: Current challenges and possible solutions. Neurol Clin Pract. 2021;11:167-174.

Devi G, Creatura C, Devi-Chou VR. Menopause related cognitive impairment. N Engl J Med. 2020;382:24:e91.

Devi G. Cognition in physicians. Presentation, American Psychiatric Association Annual Meeting, May 2019, New York.

Devi G, Creatura C, Devi-Chou VR. Menopause related cognitive impairment. N Engl J Med. 2020;382(24):e91.

Devi G. Alzheimer's disease in physicians: Assessing professional competence and tempering stigma. N Engl J Med. 2018;378:1073-1075.

Devi G. Audio interview: Assessment and support for physicians with Alzheimer's disease. Supplement to N Engl J Med, 2018.

Devi G, Scheltens P. Heterogeneity of Alzheimer's disease: Consequences for drug trials. Alzheimers Res Ther. 2018;10:122:1-3.

Devi G. Menopause related cognitive impairment. Obstet Gynecol. 2018;132:1325-1327. (Accompanying editorial.)

Devi G. Creativity in medicine. Neurology. 2015;84(5):e55-e55.

Devi G. Book review: Compact Clinical Guide to Women's Pain Management: An Evidence-Based Approach for Nurses. J Palliat Care. 2014;30(3):194.

Devi G, Voss H, Levine D, et al. Open-label, short-term repetitive transcranial magnetic stimulation in Alzheimer's patients with functional imaging correlates and literature review. Am J Alzheimers Dis Other Demen. 2014;29(3):248-255.

Devi G. Motor disorders in dementia syndromes. Chapter in Textbook of Motor Disorders, 3rd Ed. Younger DS, Ed. Lippincott Williams & Wilkins, 2013.

Devi G, Suguigichi F, Pedersen AT, et al. Current attitudes, use, and prescription of hormone therapy among New York City gynecologists. Menopause. 2013;19(3):313.

Devi G, Levine D, Voss H, et al. Functional imaging and neurocognitive correlates of targeted high-frequency repetitive transcranial magnetic stimulation in patients with Alzheimer's disease. American Academy of Neurology Annual Meeting, April 2012, New Orleans.

Devi G, Shin E, Heier L, et al. An off-label exploratory study of the efficacy and safety of repetitive transcranial magnetic stimulation in aphasia in Alzheimer's disease. American Academy of Neurology Annual Meeting, April 2010, Toronto.

Devi G, Shin E, Voss H, et al. An off-label exploratory study of the efficacy and safety of repetitive transcranial magnetic stimulation in aphasia in Alzheimer's disease. Neurology. 2010;74(9 Suppl 2):A480.

Devi G, Zhivotovskaya E, Schultz S, et al. Which presidents are the most memorable? Am J Alzheimers Dis Other Demen. 2010;25(1):32-36.

Devi G, Zhivotovskaya E, Kim E, Lo V. AMWA position statement on emergency contraception. J Womens Health. 2009;18(10):1539-40.

Devi G, Golowski M, Shin E. AMWA position statement: Genetic testing. J Womens Health. 2009;18(6):785-6.

Devi G, Golowski M, Shin E. AMWA position statement on abortion and reproductive rights. J Womens Health. 2009;18(3):299-300.

Devi G, Shin E, Halper J, Lowe S. Case report on the efficacy and safety of repetitive transcranial magnetic coil stimulation in aphasia in Alzheimer's disease. Eur J Neurol. 2009;16(Suppl 3):335-336.

Devi G, Lo V, Golowski M, et al. Gynecologists' beliefs regarding hormone therapy for Alzheimer's dementia and depression. North American Menopause Society 20th Annual Meeting, Oct 2009, San Diego.

Devi G, Golowski M, Lo V, et al. Current opinion of American (New York City) gynecologists on indications and contraindications for hormone therapy. North American Menopause Society 20th Annual Meeting, Oct 2009, San Diego.

Devi G, Golowski M, Torenson A. Hormone therapy self-use versus prescription practices of American gynecologists subsequent to the Women's Health Initiative study. 8th European Congress on Menopause, May 2009, London.

Devi G, Golowski M, Shin E; American Medical Women's Association. AMWA position statement: Cervical cancer prevention. J Womens Health. 2009;18(2):153-154.

Devi G. Neurological disorders in women. Chapter in Women's Global Health and Human Rights. Murthy P, Smith CL, Eds. Jones & Bartlett, 2009.

Devi G, Schultz S, Khosrowshahi L, et al. A retrospective chart review of the tolerability and efficacy of intravenous immunoglobulin in the treatment of Alzheimer's disease. J Am Geriatr Soc. 2008;56(4):772-4.

Devi G, Zhivotovskaya E, et al. Which presidents are the most memorable? European Federation of Neurological Societies, 12th Congress, Aug 2008, Madrid.

Devi G, Sarah S, Lynn K, et al. A retrospective chart review of the tolerability and efficacy of intravenous immunoglobulin in the treatment of Alzheimer's disease. Gerontological Society of America, Nov 2007.

Devi G, Massimi S, Schultz S, et al. A double-blind, placebo-controlled trial of donepezil for the treatment of menopause-related cognitive loss. North American Menopause Society Meeting, Oct 2007.

Devi G, Massimi S, Schultz S, et al. A double-blind, placebo-controlled trial of donepezil for the treatment of menopause-related cognitive loss. Gend Med. 2007;4(2):352-356.

Devi G, Hahn K, Massimi S, Zhivotovskaya E. The prevalence of memory complaints in a community of peri-menopausal women. Gend Med. 2005;2(4):255-264.

Devi G. Motor disorders in dementia syndromes. Chapter in Textbook of Motor Disorders, 2nd Ed. Younger DS, Ed. Lippincott Williams & Wilkins, 2005;599-606.

Devi G, Williamson J, Ottman R, et al. Early onset Alzheimer\'s disease and familial co-aggregation with psychiatric disorders. J Neuropsychiatry Clin Neurosci. 2004;16(1):57-62.

Devi G. Book review: Diseases of the Nervous System: Clinical Neuroscience and Therapeutic Principles, 3rd Ed. Ashbury AK, McKhann GM, McDonald WI, et al, Eds. Neuropsychiatry Clin Neurosci. 2003;15:381-382.

Devi G. Management of drug and alcohol withdrawal. N Engl J Med. 2003;349(4):405-7.

Devi G. My patient, the doctor and me. Chapter in This Side of Doctoring: Reflections from Women in Medicine. Lo Chin E, Ed. Sage Publications, 2002.

Devi G, Hahn K, Fox S. Screening for cognitive and depressive symptoms among peri- and post-menopausal women. North American Menopause Society Meeting, Oct 2001.

Fox S, Devi G. A five-minute self-administered screening tool for assessing risk factors in menopausal women. North American Menopause Society Meeting, Oct 2001.

Devi G, Marrero C. The effectiveness of cognitive rehabilitation for memory and cognitive loss associated with menopause. North American Menopause Society Meeting, Sept 2000.

Devi G, Silver J. Approaches to memory loss in neuropsychiatric disorders. Semin Clin Neuropsychiatry. 2000;4(5):259-265.

Devi G. Book review: Diagnosis and Management of Dementia: A Manual for Memory Disorders Teams. Wilcock GK, Bucks RS, Rockwood K, Eds. J Neuropsychiatry Clin Neurosci. 2000;12:281-282.

Devi G, Fotiou A, Jyrinji D, et al. Novel presenilin 1 mutations associated with early onset dementia in a family with both early-onset and late-onset Alzheimer\'s disease. Arch Neurol. 2000;57:1454-57.

Devi G, Ottman R, Tang MX, et al. Familial aggregation of Alzheimer\'s disease among Caucasians, African Americans, and Caribbean Hispanics in Northern Manhattan. Arch Neurol. 2000;57:72-77.

Massoud F, Devi G, Moroney JT, et al. The role of routine laboratory studies and neuroimaging in the diagnosis of dementia: A clinicopathologic study. J Am Geriatr Soc. 2000;48:1204-1210.

Devi G, Quitschke W. Alois Alzheimer: His life and times. Alzheimer Dis Assoc Disord. 1999;13:132-137.

Devi G, Ottman R, Tang MX, et al. Influence of the APOE genotype on familial aggregation of Alzheimer\'s disease among Caucasians, African Americans, and Caribbean Hispanics in Northern Manhattan. Neurology. 1999;53:789-794.

Devi G, Ottman R, Tang MX, et al. Familial aggregation of Alzheimer\'s disease among Caucasians, African Americans, and Caribbean Hispanics in Northern Manhattan. American Academy of Neurology Meeting, April 1999, Toronto.

Massoud F, Devi G, Stern Y, et al. A clinico-pathologic comparison of community-based and clinic-based cohorts of patients with dementia. Arch Neurol. 1999;56:1368-1373.

Devi G, Fotiou A, Gonzalez A, et al. Clinical features of very early onset (ages 27-35) familial Alzheimer\'s disease. J Neuropsychiatry Clin Neurosci. 1999;11:139.

Devi G, Ottman R, Tang M, et al. Familial aggregation of Alzheimer\'s disease and the influence of the APOE genotype among Caucasians, African Americans, and Caribbean Hispanics in Northern Manhattan. Ann Neurol. 1998;44:396.

Devi G, Marder K, Schofield PW, et al. Validity of family history for the diagnosis of dementia among siblings of patients with late onset Alzheimer\'s disease. Genet Epidemiol. 1998;15:215-223.

Devi G. Estrogen in Alzheimer\'s disease. Prim Psychiatry. 1997;4(10):58-63.

Devi G, Loreck R. Alois Alzheimer: Influential alienist. American Academy of Neurology Meeting, April 1997, Boston.

Devi G, Loreck R. Alois Alzheimer: Influential alienist. Neurology. 1997;48:263.

Ramachandran G, Glickman L, Levenson J, Rao C. The incidence of extrapyramidal syndromes in hospitalized patients with AIDS and a comparison group. J Neuropsychiatry Clin Neurosci. 1997;9:579-583.

Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. Neurology. 1997;49:142-146.

Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1 associated cognitive/motor disorder. Neurology. 1996;47:1247-53.

Ramachandran G, Marder K, Tang M, et al. The apolipoprotein E genotype and psychiatric manifestations of Alzheimer\'s disease. Neurology. 1996;47:256-259.

Ramachandran G, Porjesz B, Begleiter H, Litke A. Cognitive evoked potentials in young males at high risk for alcoholism. Alcohol Clin Exp Res. 1996;20(1):9-15.

Schofield P, Marder K, Dooneief G, Bell K, Chun M, Ramachandran G, et al. Subjective memory complaints predict decline in memory and cognition at one year follow-up in individuals with cognitive impairment. Neurology. 1996;46(suppl):434.